[ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#provenance", "@graph": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-7641-6446" } ] } ] }, { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#pubInfo", "@graph": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "ONZ2cjHiYvujzxAAsURK4gDhLswbE1v/AtFzeBhybK/j5B4EbFUipnx1Ix5lODeB86s8RE6aDz1PZoQuMUej1as3WP7tUgDNvI/FRtSAp9W4rsRUpNVYuEmcvy83vrHpXXavUM70b0VOCsnNSN8LqOBjM29n8cA3uZ67Q7m7FNw=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY" } ] }, { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY", "http://www.w3.org/ns/prov#generatedAtTime": [ { "@value": "2022-09-16T11:50:48.517240", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-1501-1082" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id": "https://w3id.org/biolink/vocab/", "http://purl.org/pav/version": [ { "@value": "2.3.0" } ] } ] }, { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#assertion", "@graph": [ { "@id": "http://identifiers.org/drugbank/DB01267", "@type": [ "https://w3id.org/biolink/vocab/Drug" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Paliperidone" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Drug" } ] }, { "@id": "http://purl.obolibrary.org/obo/MONDO_0001087", "@type": [ "https://w3id.org/biolink/vocab/Disease" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Schizotypal personality disorder" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#association", "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [ { "@id": "http://purl.obolibrary.org/obo/MONDO_0001087" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [ { "@id": "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [ { "@id": "http://identifiers.org/drugbank/DB01267" } ], "@type": [ "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Similarly, De Cos Milas et al. [6] described their clinical experience with paliperidone in adolescents. They presented 3 males and 2 females, age between 15 and 17 years. Diagnoses were autism, borderline personality disorder, schizotypal personality disorder, personality disorder not otherwise specified, and schizophrenia. Prescribed dose was 3–9 mg/day, and actual mean time of treatment duration is 5.8 months. In 4 cases, paliperidone was initiated as a change from other antipsychotic. There were no adverse effects that required discontinuation and in all cases symptoms improved." } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source": [ { "@id": "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" } ], "https://w3id.org/biolink/vocab/has_population_context": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#context" } ], "https://w3id.org/biolink/vocab/publications": [ { "@id": "http://www.ncbi.nlm.nih.gov/pubmed/31096228" } ], "https://w3id.org/biolink/vocab/relation": [ { "@id": "http://purl.obolibrary.org/obo/NCIT_C94303" } ] }, { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#context", "@type": [ "https://w3id.org/biolink/vocab/Cohort" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "Adolescents (15-17)" } ], "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Cohort" } ] } ] }, { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#Head", "@graph": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAIztrMHG-yYosqB5N47FjRMlURxJBBMUwpw6xRf8onFY#pubInfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] } ]